Uncategorized

Regeneron wades into radiopharma through $40M upfront deal with Telix

Published

1 week ago

on

Regeneron is set to work on radiopharmaceuticals for the first time in a new partnership to develop solid tumor therapies as well as diagnostic agents with Telix Pharmaceuticals.

Under the 50/50 …

Related Topics:

Leave a Reply

Your email address will not be published. Required fields are marked *

Trending

Exit mobile version